Aortitis other imaging findings: Difference between revisions
No edit summary |
m Bot: Removing from Primary care |
||
(One intermediate revision by the same user not shown) | |||
Line 11: | Line 11: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[CME Category::Cardiology]] | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Line 16: | Line 20: | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Up-To-Date cardiology]] | [[Category:Up-To-Date cardiology]] | ||
Latest revision as of 20:27, 29 July 2020
Aortitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Aortitis other imaging findings On the Web |
American Roentgen Ray Society Images of Aortitis other imaging findings |
Risk calculators and risk factors for Aortitis other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2] Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [3]
Overview
Other diagnostic studies for aortitis include PET scan, which demonstrates uptake of Fluorine-18-fluorodeoxyglucose in the aorta and periaortic activity. The uptake of Fluorine-18-fluorodeoxyglucose in vascular structures is considered abnormal.[1]
Other Imaging Findings
Other diagnostic studies for aortitis include PET scan, which demonstrates uptake of Fluorine-18-fluorodeoxyglucose in the aorta and periaortic activity. The uptake of Fluorine-18-fluorodeoxyglucose in vascular structures is considered abnormal.[1]
References
- ↑ 1.0 1.1 Hartlage GR, Palios J, Barron BJ, Stillman AE, Bossone E, Clements SD; et al. (2014). "Multimodality imaging of aortitis". JACC Cardiovasc Imaging. 7 (6): 605–19. doi:10.1016/j.jcmg.2014.04.002. PMID 24925329.